Abstract. The aim of the present study was to examine the risk factors of high-output ileostomy (HOI), which is associated with electrolyte abnormalities and/or stoma complications, and to create a prediction model. The medical records of 68 patients who underwent colorectal cancer surgery with ileostomy between 2011 and 2016 were retrospectively investigated. All the patients underwent surgical resection for colorectal cancer at the Osaka Medical Center for Cancer and Cardiovascular Diseases (Osaka, Japan). A total of 7 patients with inadequate data on ileostomy output were excluded. Using a group of 50 patients who underwent surgery between 2011 and 2013, the risk of HOI was classified by a decision tree model using a partition platform. The HOI prediction model was validated in an additional group of 11 patients who underwent surgery between 2014 and 2016. Univariate analysis of clinical factors demonstrated that young age (P=0.003) and high white blood cell (WBC) count (P<0.001) after surgery were significantly correlated with HOI. Operative factors, such as surgical procedure, approach, operative time and blood loss, were not significantly correlated with HOI. Using these clinical factors, the risk of HOI was classified by statistical partition. In this model, three factors (gender, age and WBC on postoperative day 1) were generated for the prediction of HOI. The patients were classified into five groups, and HOI was observed in 0-88% of patients in each group. The area under the curve (AUC) was 0.838. The model was validated by an external dataset in an independent patient group, for which the AUC was 0.792. In conclusion, HOI patients were classified and an HOI prediction model was developed that may help clinicians in postoperative care.
Introduction
Surgery is an effective treatment for colorectal cancer (CRC) (1, 2) , and certain procedures, such as low anterior resection and intersphincteric resection for lower rectal cancer, require an ileostomy to reduce the risk of severe anastomotic leakage (3) (4) (5) . High-output ileostomy (HOI) is often observed and is accompanied by electrolyte abnormalities and/or stoma complications (6) (7) (8) .
The aim of the present study was to determine the frequency and risk factors of HOI and to create a prediction model of HOI. Predicting HOI may be useful for perioperative treatment.
Patients and methods
Patients and data sets. A total of 68 consecutive patients who underwent surgery for colorectal cancer with ileostomy at the Osaka Medical Center for Cancer and Cardiovascular Diseases (Osaka, Japan) between 2011 and 2016 were retrospectively analyzed. HOI was defined by a maximum output of >2,000 ml/day and high output (>1,000 ml/day) lasting for >3 days (Fig. 1) . A total of 7 patients for whom detailed data of output were unavailable were excluded (Fig. 2) . Based on a group of 50 patients who underwent surgery between 2011 and 2013, a decision tree was used to develop a prediction model for HOI. Clinicopathological factors, such as patient sex, age, body mass index, tumor stage, procedure, operative approach, resection of other organs, operative time, blood loss, white blood cell (WBC) count on postoperative day (POD)1, and C-reactive protein levels on POD3, were assessed. These patients were included in a training set (TS) and classified by statistical partition. A total of 11 patients treated between 2014 and 2016 were included in a validation set (VS). The classification model was validated in this independent group. The present retrospective study was approved by the Osaka Medical Center for Cancer and Cardiovascular Diseases Ethics Committee, and written informed consent was obtained from all the patients. 
Results

Patient characteristics.
The clinicopathological characteristics of all 61 patients (50 TS and 11 VS patients), are listed in Table I . HOI was observed in 19 patients in the TS and 3 patients in the VS. Recently, the increasing use of laparoscopic surgery Normal WBC ≥3,500 and ≤9,900 cells/µl. f The maximum ileostomy output was >2,000 ml, and high output (>1,000 ml) lasted for >3 days.
g Patients who did not have high output status. BMI, body mass index; ISR, intersphincteric resection; LAR, low anterior resection; POD, postoperative day; WBC, white blood cell; WNL, within normal limits; CRP, C-reactive protein; HOI, high-output ileostomy. has led to more laparoscopic surgeries being performed in the VS compared with the TS (P=0.002). The operative time was longer (P=0.006) and blood loss was lower (P=0.022) in the TS.
Univariate analysis of clinicopathological factors of HOI in the TS.
The results of the univariate analysis of the clinicopathological factors of HOI in the TS are shown in Table II . Young age (P=0.003) and high WBC count on POD1 (P=0.041) were significant factors in HOI. Operative factors, such as surgical procedure, approach, operative time and blood loss, were not found to be significant. Using these clinical factors, the risk of HOI was classified using JMP 11.0 Partition (SAS Institute). In this model, three factors (gender, age and WBC on POD1) were generated for the prediction of HOI. The results generated by the statistical analysis using the clinical factors in relation to HOI are shown Fig. 3 . The patients were classified into five groups. The rate of HOI ranged from 0 to 88% in each Normal WBC is ≥3,500 and ≤9,900 cells/µl. HOI, high-output ileostomy; TS, training set; BMI, body mass index; ISR, intersphincteric resection; LAR, low anterior resection; POD, postoperative day; WBC, white blood cell; WNL, within normal limits; CRP, C-reactive protein. Figure 3 . The partition that classified the HOI patients. The patients in the TS were classified into five groups using three factors, namely patient age, sex, and WBC on POD1. There were 7 patients (88%) with HOI in group 1, 9 patients (53%) with HOI in group 2, 2 patients (20%) with HOI in group 3, 1 patient (11%) with HOI in group 4, and 0 patients (0%) with HOI in group 5. HOI, high-output ileostomy; TS, training set; POD, postoperative day; WBC, white blood cell; WNL, within normal limits.
group, and this model was able to distinguish the high-risk group of HOI. The area under the curve (AUC) was 0.838 in the TS (Fig. 4) . The model was validated by an external dataset in an independent patient group between 2014 and 2016, with an AUC of 0.792.
Discussion
Loperamide and codeine phosphate are widely prescribed to treat non-perioperative HOI (9,10). Although these pharmacological agents reduce ileostomy output, they are not commonly used in perioperative HOI treatment, as the perioperative use of opioids has been shown to increase the risk of ileus (11) . It has been reported that Clostridium difficile (C. difficile) infection often occurs in HOI (12); however, C. difficile was not detected in our cases (data not shown).
High WBC after surgery was associated with HOI in the present study, and inflammation was reported to be associated with severe diarrhea from bacterial infection and inflammatory bowel disease (13, 14) . Inflammation is a protective host response to foreign antigenic challenge or tissue injury; however, an overactive immune response may lead to loss of tissue structure as well as function. The omega-3 fatty acid eicosapentaenoic acid (EPA) was reported to reduce the bowel inflammation that results in diarrhea (15, 16) . EPA counter-regulates leukocyte-mediated tissue injury and proinflammatory gene expression (15) . It has been reported that nutritional management is important in HOI treatment (7, 8) . Recent studies have reported that ProSure™ (Abbot Japan Co., Ltd, Tokyo, Japan), an EPA-containing supplement, affects the nutritional status and quality of life in advanced cancer patients (17, 18) . ProSure™ was introduced in postoperative nutritional management and the ileostomy output was examined. An additional 12 consecutive patients were enrolled in the EPA group managed by ProSure™. The maximum oral ProSure™ intake was set at 480 ml (EPA, 2 g) and it was freely consumed by each patient after surgery. Two patients who could not consume the drink due to its taste were excluded. The median ProSure™ intake was 300 ml (range, 240-480 ml) and the median EPA intake was 1,320 mg (range, 1056-2112 mg). The clinicopathological factors of the EPA group are shown in Table III . The ileostomy output did not differ significantly between the TS and EPA groups, but the rate of HOI was lower in the EPA group (10%) compared with that in the non-EPA group. Thus, nutritional management with EPA may help reduce the risk of HOI in patients according to the prediction model. Normal WBC is ≥3,500 and ≤9,900 cells/µl. f The maximum ileostomy output was >2,000 ml, and high output (>1,000 ml) lasted for >3 days.
g Patients who did not have high output status. TS, training set; EPA, eicosapentaenoic acid; BMI, body mass index; ISR, intersphincteric resection; LAR, low anterior resection; POD, postoperative day; WBC, white blood cell; WNL, within normal limits; CRP, C-reactive protein; HOI, high-output ileostomy.
In summary, patients with HOI were classified using a prediction model. This model may provide clinicians with useful information for postoperative care.
